Maisha marefu schreef op 25 mei 2021 09:49:
Media Release
IMMUTEP TO PRESENT AT THE JEFFERIES VIRTUAL HEALTHCARE CONFERENCE
SYDNEY, AUSTRALIA – 25 May 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the
Company”), a biotechnology company developing novel immunotherapy treatments for cancer and
autoimmune disease, announced today that Immutep CEO Marc Voigt has been invited to participate in the
Jefferies Virtual Healthcare Conference, which is taking place from June 1st to 4th
.
During this virtual conference, Mr. Voigt is scheduled to conduct a corporate presentation followed by a
Q&A session along with Immutep’s Chief Scientific and Medical Officer, Dr. Frederic Triebel, starting at
12:30 pm ET on June 4
th
. A live webcast of this event will be available at
wsw.com/webcast/jeff174/immp/1858869Further details about the Jefferies Virtual Healthcare Conference can be found at
www.jefferies.com/IdeasAndPerspective...